Picture of RegenETP, logo

RGTPQ — RegenETP, News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro Cap

Brief: Polarityte Reports Second Quarter Financial Results And Provides Business Update

Aug 12 (Reuters) - PolarityTE Inc  PTE.O :
    * POLARITYTE REPORTS SECOND QUARTER FINANCIAL RESULTS AND
PROVIDES
BUSINESS UPDATE
    * Q2 REVENUE $2.54 MILLION
    * Q2 REVENUE ESTIMATE $3.2 MILLION -- REFINITIV IBES DATA
    * REPORTED SKINTE MET PRIMARY AND SECONDARY ENDPOINTS IN
FINAL
ANALYSIS FROM DIABETIC FOOT ULCER (DFU) TRIAL
    * CEASED COMMERCIAL SALES OF SKINTE ON MAY 31, AND HAS MADE
SUBSTANTIAL REDUCTIONS IN COSTS ASSOCIATED WITH ITS COMMERCIAL
OPERATIONS
    * ON JULY 23, 2021 COMPANY SUBMITTED TO FDA AN IND FOR
SKINTE FOR
TREATMENT OF CHRONIC CUTANEOUS ULCERS.
    * QTRLY LOSS PER SHARE $0.06

Source text for Eikon:  ID:nBw9DSh12a 
Further company coverage:  PTE.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on RegenETP,

See all news